The evolving definition of treatment resistance.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1999-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 10372602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study.

  1997cited by this paper
• One hundred years of schizophrenia: a meta-analysis of the outcome literature.

  1994cited by this paper
• Time course and biologic correlates of treatment response in first-episode schizophrenia.

  1993cited by this paper
• Dimensions of Outcome with Clozapine

  1992cited by this paper
• Comorbidity of schizophrenia and substance abuse: implications for treatment.

  1992cited by this paper
• Defining treatment refractoriness in schizophrenia.

  1990cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• Prognosis and outcome using broad (DSM-II) and narrow (DSM-III) concepts of schizophrenia.

  1984cited by this paper
• The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment

  1983cited by this paper
• Important issues in the drug treatment of schizophrenia.

  1980cited by this paper

• Treatment target in schizophrenia: a critical review and a clinical suggestion.

  2025cites this paper
• Advances in Synthetic Lethality in Potential Oncology Therapeutic Approaches.

  2025cites this paper
• Negative symptoms in treatment-resistant schizophrenia and its relationship with functioning.

  2024cites this paper
• Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

  2024cites this paper
• Treatment Resistance in Schizophrenia and Depression as an Interactive Kind: Mapping the Development of a Classification through Meta-Narrative Review

  2024cites this paper
• m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

  2023cites this paper
• Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia

  2022cites this paper
• Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia

  2021cites this paper
• Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post‐traumatic stress disorder

  2021cites this paper
• Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. SHORT COMMUNICATION Running title: peripheral inflammation is associated with ultraresistant schizophrenia

  2020cites this paper
• Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis.

  2018cites this paper
• Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort

  2018cites this paper
• m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.

  2017cites this paper
• Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice

  2017cites this paper
• Assessment of prescription pattern of cataract patients in the ophthalmology department at a tertiary health care institution

  2017cites this paper
• Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study

  2016cites this paper
• Is non-pharmacological treatment an option for certain schizophrenia patients?

  2014cites this paper
• Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.

  2014cites this paper
• Schizophrenia-negative symptoms: a real, lasting challenge. Retrospective and cross-sectional study

  2014cites this paper
• Patients with Poor Response to Antipsychotics Have a More Severe Pattern of Frontal Atrophy: A Voxel-Based Morphometry Study of Treatment Resistance in Schizophrenia

  2014cites this paper
• Anti-microbials, Drug Utilization Study, Intra ocular lens, Cataract, Prophylactic, Post-operative

  2013cites this paper
• Treatment-Resistant Schizophrenia: Prevalence and Risk Factors

  2013cites this paper
• Drug Prescribing Pattern, Intra ocular lens, Cataract, Prophylactic, Post-operative, Steroids, Anti-microbials, Mydriatics

  2013cites this paper
• DRUG UTILISATION STUDY IN INTENSIVE CARDIAC CARE UNIT AT A TERTIARY CARE HOSPITAL

  2013cites this paper
• ROLE OF ANTIMICROBIALS IN INTRA OCULAR LENS (IOL) IMPLANTATION

  2013cites this paper
• DRUG PRESCRIBING PATTERN IN CATARACT SURGERY BY INTRA - OCULAR LENS IMPLANTATION

  2013cites this paper
• Refractoriness in Bipolar Disorder: Definitions and Evidence‐Based Treatment

  2012cites this paper
• Evolution of the Concept of Treatment-resistant Schizophrenia: Toward a Reformulation for Lack of an Adequate Response

  2012cites this paper
• POUR LE DIPLOME D'ETAT DE DOCTEUR EN MEDECINE Discipline : Psychiatrie Présentée et soutenue publiquement le 19 mars 2012 A Créteil

  2012cites this paper
• A Case of Recurrent Priapism in the Context of Quetiapine Use, Discontinuation, and Rechallenge

  2011cites this paper
• A case of recurrent priapism in the context of quetiapine use, discontinuation, and rechallenge.

  2011cites this paper
• Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry

  2011cites this paper
• A Case of Recurrent Priapism in the Context of Quetiapine Use, Discontinuation, and Rechallenge

  2011cites this paper
• The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.

  2011cites this paper
• The evolving concept of Treatment- Resistant Schizophrenia.

  2011cites this paper
• A Case of Recurrent Priapism in the Context of Quetiapine Use, Discontinuation, and Rechallenge

  2011cites this paper
• A Case of Recurrent Priapism in the Context of Quetiapine Use, Discontinuation, and Rechallenge

  2011cites this paper
• Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders

  2010cites this paper
• Risperidone for Individuals with Refractory Schizophrenia

  2010cites this paper
• Duration of Untreated Psychosis and Premorbid Functioning: Relationship with Treatment Response and Treatment-Resistant Schizophrenia

  2010cites this paper
• History and Current Definitions of Treatment-Resistant Schizophrenia

  2010cites this paper
• Treatment Response in Psychotic Patients in a Naturalistic Setting : Classification, Genes, Drugs, Insight and Social Networks

  2009influential citation
• Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.

  2009influential citation
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 88 Treatment Response in Psychotic Patients in a Naturalistic Setting Classification , Genes , Drugs , Insight and Social Networks

  2009influential citation
• Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors

  2008cites this paper
• Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors.

  2008cites this paper
• Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).

  2008cites this paper
• Antipsychotic Medication Utilization Trends Among Texas Veterans: 1997–2002

  2008cites this paper
• Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.

  2008cites this paper
• EPILOGUE: Translational Models for the 21st Century: Reminiscence, Reflections, and Some Recommendations

  2008cites this paper
• Treatment-resistant schizophrenia.

  2007cites this paper
• [Refractory schizophrenia].

  2007cites this paper
• Refractory schizophrenia Esquizofrenia refratária

  2007cites this paper
• Esquizofrenia refratária Refractory schizophrenia

  2007cites this paper
• PHARMACOGENETIQUE DE LA SCHIZOPHRENIE

  2007cites this paper
• Treatment-Resistant Schizophrenia.

  2007cites this paper
• Dealing with treatment resistance to clozapine : characteristics of treatment response in schizophrenia

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Pharmakotherapie der Schizophrenie

  2006cites this paper
• Management of treatment resistant schizophrenia

  2006cites this paper
• Selecting Patients for Long-acting Novel Antipsychotic Therapy

  2006cites this paper
• [Pharmacotherapy for schizophrenia].

  2006cites this paper
• Antipsychotic drug utilization patterns and treatment -emergent diabetes: A methodological comparison of incidence using a claims database

  2006cites this paper
• Augmentation Strategies in Clozapine-Resistant Schizophrenia

  2005cites this paper
• Augmentation With Amisulpride for Schizophrenic Patients Nonresponsive to Antipsychotic Monotherapy

  2005cites this paper
• Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

  2005cites this paper
• Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.

  2004cites this paper
• Concept and Management of Treatment Resistant Schizophrenia (TRS)

  2004cites this paper
• Treatment-refractory schizophrenia

  2004cites this paper
• High-dose olanzapine for treatment-refractory schizophrenia.

  2003cites this paper
• Substantial increase in number and dosage of antipsychotics in non-responsive vs. responsive schizophrenia inpatients

  2003cites this paper
• [Cerebrospinal fluid filtration as experimental therapy in therapy refractory psychoses in Borna disease virus seropositive patients. Therapeutic effects, findings].

  2003cites this paper
• Liquorfiltration als experimentelle Therapie bei therapieresistenten Psychosen Borna-Disease-Virus-seropositiver Patienten

  2003cites this paper
• Managing patients with “treatment‐resistant” schizophrenia

  2003cites this paper
• Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study.

  2002cites this paper
• When symptoms persist: clozapine augmentation strategies.

  2001cites this paper
• Atypical antipsychotic medications: Pharmacological profiles and psychological implications.

  2000cites this paper